ATA16597A - Neue substituierte p-sulfonylaminobenzol- sulfonsäureamide - Google Patents

Neue substituierte p-sulfonylaminobenzol- sulfonsäureamide

Info

Publication number
ATA16597A
ATA16597A AT0016597A AT16597A ATA16597A AT A16597 A ATA16597 A AT A16597A AT 0016597 A AT0016597 A AT 0016597A AT 16597 A AT16597 A AT 16597A AT A16597 A ATA16597 A AT A16597A
Authority
AT
Austria
Prior art keywords
sulfonylaminobenzol
sulfonic acid
new substituted
substituted
new
Prior art date
Application number
AT0016597A
Other languages
English (en)
Inventor
Michael Dr Hartmann
Peter Dr Kremminger
Heinz Dr Blaschke
Dagmar Dr Stimmeder
Harald Dr Fellier
Franz Dr Rovenszky
Original Assignee
Nycomed Austria Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Austria Gmbh filed Critical Nycomed Austria Gmbh
Priority to AT0016597A priority Critical patent/ATA16597A/de
Priority to PCT/GB1998/000342 priority patent/WO1998033769A1/en
Priority to US09/355,722 priority patent/US6297282B1/en
Priority to DE69815311T priority patent/DE69815311D1/de
Priority to AT98902137T priority patent/ATE242206T1/de
Priority to AU58754/98A priority patent/AU5875498A/en
Priority to JP53266098A priority patent/JP2001509800A/ja
Priority to EP98902137A priority patent/EP0968180B1/de
Publication of ATA16597A publication Critical patent/ATA16597A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/64—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
    • C07C323/67—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfonamide groups, bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AT0016597A 1997-02-03 1997-02-03 Neue substituierte p-sulfonylaminobenzol- sulfonsäureamide ATA16597A (de)

Priority Applications (8)

Application Number Priority Date Filing Date Title
AT0016597A ATA16597A (de) 1997-02-03 1997-02-03 Neue substituierte p-sulfonylaminobenzol- sulfonsäureamide
PCT/GB1998/000342 WO1998033769A1 (en) 1997-02-03 1998-02-03 Substituted derivatives of benzosulphonamides as inhibitors of the enzyme cyclooxygenase ii
US09/355,722 US6297282B1 (en) 1997-02-03 1998-02-03 Substituted derivatives of benzosulphonamides as inhibitors of the enzyme cyclooxygenase II
DE69815311T DE69815311D1 (de) 1997-02-03 1998-02-03 Substituierte derivate von benzosulphonamiden als hemmer des enzym cyclooxygenase ii
AT98902137T ATE242206T1 (de) 1997-02-03 1998-02-03 Substituierte derivate von benzosulphonamiden als hemmer des enzym cyclooxygenase ii
AU58754/98A AU5875498A (en) 1997-02-03 1998-02-03 Substituted derivatives of benzosulphonamides as inhibitors of the enzyme cyclo oxygenase ii
JP53266098A JP2001509800A (ja) 1997-02-03 1998-02-03 酵素シクロオキシゲナーゼ▲ｉｉ▼の阻害剤としてのベンゾスルホンアミドの置換された誘導体
EP98902137A EP0968180B1 (de) 1997-02-03 1998-02-03 Substituierte derivate von benzosulphonamiden als hemmer des enzym cyclooxygenase ii

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0016597A ATA16597A (de) 1997-02-03 1997-02-03 Neue substituierte p-sulfonylaminobenzol- sulfonsäureamide

Publications (1)

Publication Number Publication Date
ATA16597A true ATA16597A (de) 1998-04-15

Family

ID=3483303

Family Applications (2)

Application Number Title Priority Date Filing Date
AT0016597A ATA16597A (de) 1997-02-03 1997-02-03 Neue substituierte p-sulfonylaminobenzol- sulfonsäureamide
AT98902137T ATE242206T1 (de) 1997-02-03 1998-02-03 Substituierte derivate von benzosulphonamiden als hemmer des enzym cyclooxygenase ii

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT98902137T ATE242206T1 (de) 1997-02-03 1998-02-03 Substituierte derivate von benzosulphonamiden als hemmer des enzym cyclooxygenase ii

Country Status (7)

Country Link
US (1) US6297282B1 (de)
EP (1) EP0968180B1 (de)
JP (1) JP2001509800A (de)
AT (2) ATA16597A (de)
AU (1) AU5875498A (de)
DE (1) DE69815311D1 (de)
WO (1) WO1998033769A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040072889A1 (en) * 1997-04-21 2004-04-15 Pharmacia Corporation Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia
US6649645B1 (en) * 1998-12-23 2003-11-18 Pharmacia Corporation Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia
US7507767B2 (en) 2001-02-08 2009-03-24 Schering Corporation Cannabinoid receptor ligands
US7067539B2 (en) 2001-02-08 2006-06-27 Schering Corporation Cannabinoid receptor ligands
US20060167074A1 (en) * 2001-06-19 2006-07-27 Norbert Muller Methods and compositions for the treatment of psychiatric disorders
DE10129320A1 (de) * 2001-06-19 2003-04-10 Norbert Mueller Verwendung von COX-2 Inhibitoren zur Behandlung von Schizophrenie, wahnhaften Störungen, affektiven Störungen oder Ticstörungen
KR20050044417A (ko) 2001-11-14 2005-05-12 쉐링 코포레이션 카나비노이드 수용체 리간드
US20030220374A1 (en) * 2002-01-14 2003-11-27 Pharmacia Corporation Compositions and methods of treatment involving peroxisome proliferator-activated receptor-gamma agonists and cyclooxygenase-2 selective inhibitors
US20030212138A1 (en) * 2002-01-14 2003-11-13 Pharmacia Corporation Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor
PE20040574A1 (es) 2002-06-19 2004-09-08 Schering Corp Agonistas de los receptores cannabinoides
US20040147581A1 (en) * 2002-11-18 2004-07-29 Pharmacia Corporation Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy
KR20050085563A (ko) 2002-12-13 2005-08-29 워너-램버트 캄파니 엘엘씨 하부요로증상을 치료하기 위한 알파-2-델타 리간드
AR043633A1 (es) 2003-03-20 2005-08-03 Schering Corp Ligandos de receptores de canabinoides
US20040220155A1 (en) * 2003-03-28 2004-11-04 Pharmacia Corporation Method of providing a steroid-sparing benefit with a cyclooxygenase-2 inhibitor and compositions therewith
DK1534305T3 (da) 2003-05-07 2007-02-05 Osteologix As Behandling af brusk-/knoglelidelser med vandoplöselige strontiumsalte
WO2005009342A2 (en) * 2003-07-16 2005-02-03 Pharmacia Corporation Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
US20050119262A1 (en) * 2003-08-21 2005-06-02 Pharmacia Corporation Method for preventing or treating an optic neuropathy with a cox-2 inhibitor and an intraocular pressure reducing agent
WO2005023189A2 (en) * 2003-09-03 2005-03-17 Pharmacia Corporation Method of cox-2 selective inhibitor and nitric oxide-donating agent
US7449462B2 (en) 2004-01-22 2008-11-11 Pfizer, Inc. Triazole derivatives which inhibit vasopressin antagonistic activity
WO2005105779A1 (en) * 2004-04-28 2005-11-10 Pfizer Limited 3-heterocyclyl-4-phenyl-triazole derivatives as inhibitors of the vasopressin v1a receptor
CA2607913C (en) * 2005-05-05 2014-03-18 Cook Biotech Incorporated Implantable materials and methods for inhibiting tissue adhesion formation
JP5308350B2 (ja) 2006-12-22 2013-10-09 レコルダーティ アイルランド リミテッド α２δリガンドおよびＮＳＡＩＤを用いた下部尿路機能障害の併用療法
US8815828B2 (en) * 2008-07-02 2014-08-26 University Of Florida Research Foundation, Inc. Therapeutic combinations for use in neoplasia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5604260A (en) * 1992-12-11 1997-02-18 Merck Frosst Canada Inc. 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2
PT848703E (pt) * 1995-07-21 2001-01-31 Nycomed Austria Gmbh Derivados de benzosulfonamidas como inibidores da enzima ciclo-oxigenase ii
DE19533644A1 (de) * 1995-09-12 1997-03-13 Nycomed Arzneimittel Gmbh Neue Benzolsulfonamide
US6146615A (en) * 1999-01-11 2000-11-14 The University Of Toledo Contrast agents for image enhancement in magnetic resonance imaging

Also Published As

Publication number Publication date
EP0968180A1 (de) 2000-01-05
EP0968180B1 (de) 2003-06-04
US6297282B1 (en) 2001-10-02
JP2001509800A (ja) 2001-07-24
WO1998033769A1 (en) 1998-08-06
DE69815311D1 (de) 2003-07-10
ATE242206T1 (de) 2003-06-15
AU5875498A (en) 1998-08-25

Similar Documents

Publication Publication Date Title
ATA16597A (de) Neue substituierte p-sulfonylaminobenzol- sulfonsäureamide
DE59803845D1 (de) Sulfinsäurederivate und deren herstellung und verwendung
GB2306958B (en) Oximesulfonic acid esters and the use thereof as latent sulfonic acids
YU35697A (en) Substituted 6,6-hetero-bicyclic derivatives
DE69429836T2 (de) Tricyclische,substituierte Pyrazolyl- benzolsulfonamide und ihre Verwendung als Cyclooxygenase II Inhibitoren
ATE231837T1 (de) Hydroxamsäure- und carbonsäurederivate mit mmp und tnf hemmender wirkung
DK633088D0 (da) Hidtil ukendte forbindelser
ES2191076T3 (es) Nuevos derivados de 1-aril-pirazol y su empleo como plaguicidas.
ATE242183T1 (de) Glaszusammensetzung zur vermeidung der alkali- kiesel-kieselsäure reaktion
ATE133954T1 (de) Substituierte cephalosporinsulfone als anti- entzündliche und anti-degenerative mittel
DE69516186T2 (de) Verwendung von Beta-Aminopropionsäure-Derivaten als Fungizide
ATE224372T1 (de) Substituierte 6-alkylphenanthridine
ES8506718A1 (es) Un procedimiento para la preparacion de derivados benzoheterociclicos.
AT388373B (de) Neue thyroninderivate
ES466794A1 (es) Un procedimiento para la preparacion de derivados de imida- zol.
ATE165089T1 (de) Thiocarbamoylverbindungen als mikrobizide
FR2366280A1 (fr) Nouvelles 1h-benzo(de)isoquinoleine-1,3(2h)-diones substituees en position 2, utiles comme agents anti-inflammatoires
ATE17490T1 (de) Dithiino (1,4) (2,3-c) pyrrolderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
DK231787D0 (da) 3-amino-dihydropyridiner, fremgangsmaade til deres fremstilling og deres anvendelse i laegemidler
ES542173A0 (es) Procedimiento para la preparacion de derivados de 9-haloge- no-prostano
NO921313L (no) Derivater av 2-spirocyklopropylcefalosporinsulfoner og deres fremstilling
ES8307812A1 (es) Un procedimiento para la preparacion de nuevos amidin derivados del acido clavulawilo.
DK354681A (da) Fremgangsmaade til fremstilling af amidiner
FI935399A (fi) N-substituerade azabicykloheptanderivat samt deras framstaellning och anvaendning

Legal Events

Date Code Title Description
A1J Withdrawal paragraph 166 lit. 6